Elliptic Laboratories ASA (OSL:ELABS)
Norway · Delayed Price · Currency is NOK 2.480
-0.020 (-0.80%)
Aug 4, 2026, 4:25 PM CET
Elliptic Laboratories ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 126.93 | 102.74 | 133.34 | 69.63 | 52.06 | 63.04 | |
Revenue Growth | -7.84% | -22.95% | 91.50% | 33.75% | -17.41% | 40.92% |
Gross Profit | 126.93 | 102.74 | 133.34 | 69.63 | 52.06 | 63.04 |
Selling, General & Admin | 92.05 | 90.44 | 87.86 | 80.55 | 62.8 | 50.81 |
Depreciation & Amortization Expenses | 25.99 | 24.76 | 20.41 | 16.22 | 11.32 | 8.31 |
Other Operating Expenses | 34.08 | 34.78 | 20.37 | 22.74 | 20.07 | 15.06 |
Total Operating Expenses | 152.12 | 149.98 | 128.63 | 119.52 | 94.19 | 74.18 |
Operating Income | -25.19 | -47.24 | 4.71 | -49.89 | -42.13 | -11.14 |
Interest Income | 3.41 | 4.55 | 16.96 | 12.19 | 17.32 | 3.73 |
Interest Expense | -12.28 | -17.34 | -4.62 | -9.31 | -14.49 | -5.68 |
Total Non-Operating Income (Expense) | -8.87 | -12.79 | 12.34 | 2.89 | 2.83 | -1.95 |
Pretax Income | -34.06 | -60.03 | 17.05 | -47 | -39.3 | -13.09 |
Provision for Income Taxes | 89.91 | 79.93 | 8.09 | -8.89 | -6.3 | -1.88 |
Net Income | -123.97 | -139.96 | 8.96 | -38.12 | -33 | -11.21 |
Net Income to Common | -123.97 | -139.96 | 8.96 | -38.11 | -33 | -11.21 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 110 | 105 | 105 | 104 | 104 | 98 |
Shares Outstanding (Diluted) | 110 | 105 | 111 | 104 | 104 | 98 |
Shares Change | 414.22% | -5.38% | 6.67% | 0.34% | 5.74% | 10.18% |
EPS (Basic) | -1.42 | -1.33 | 0.09 | -0.37 | -0.31 | -0.11 |
EPS (Diluted) | -1.43 | -1.33 | 0.08 | -0.37 | -0.31 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -23.7 | 5.96 | -10.61 | -46.02 | -17.34 | -10.82 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.22 | 0.06 | -0.10 | -0.44 | -0.17 | -0.11 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -19.85% | -45.98% | 3.53% | -71.65% | -80.92% | -17.67% |
Profit Margin | -97.67% | -136.23% | 6.72% | -54.74% | -63.38% | -17.79% |
FCF Margin | -18.67% | 5.80% | -7.95% | -66.09% | -33.31% | -17.17% |
EBITDA | 2.24 | -21.92 | 26.57 | -33.67 | -30.81 | -2.83 |
EBITDA Margin | 1.76% | -21.33% | 19.93% | -48.35% | -59.19% | -4.49% |
EBIT | -25.19 | -47.24 | 4.71 | -49.89 | -42.13 | -11.14 |
EBIT Margin | -19.85% | -45.98% | 3.53% | -71.65% | -80.92% | -17.67% |
Effective Tax Rate | -263.97% | -133.15% | 47.43% | 18.91% | 16.04% | 14.34% |